262 related articles for article (PubMed ID: 28848179)
41. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.
Petri M; Naqibuddin M; Carson KA; Wallace DJ; Weisman MH; Holliday SL; Sampedro M; Narayana S; Fox PT; Franklin C; Padilla PA; Brey RL
J Rheumatol; 2008 Dec; 35(12):2348-54. PubMed ID: 18793003
[TBL] [Abstract][Full Text] [Related]
42. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
43. Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.
Wang HP; Wang CY; Pan ZL; Zhao JY; Zhao B
Chin Med J (Engl); 2016 Mar; 129(5):542-8. PubMed ID: 26904988
[TBL] [Abstract][Full Text] [Related]
44. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
45. Elevated cerebrospinal fluid interleukin-17A and interferon-γ levels in early asymptomatic neurosyphilis.
Pastuszczak M; Jakiela B; Wielowieyska-Szybinska D; Jaworek AK; Zeman J; Wojas-Pelc A
Sex Transm Dis; 2013 Oct; 40(10):808-12. PubMed ID: 24275734
[TBL] [Abstract][Full Text] [Related]
46. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
47. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.
Tan Z; Zhou Y; Li X; Wang G; Tao J; Wang L; Ma Y; Li X
Clin Rheumatol; 2018 Jan; 37(1):227-233. PubMed ID: 29103181
[TBL] [Abstract][Full Text] [Related]
48. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
Thanou A; Stavrakis S; Dyer JW; Munroe ME; James JA; Merrill JT
Arthritis Res Ther; 2016 Sep; 18(1):197. PubMed ID: 27590046
[TBL] [Abstract][Full Text] [Related]
49. Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus.
Abo-Shanab AM; Kholoussi S; Kandil R; Dorgham D
Lupus; 2021 Mar; 30(3):459-464. PubMed ID: 33183127
[TBL] [Abstract][Full Text] [Related]
50. Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.
Svenungsson E; Andersson M; Brundin L; van Vollenhoven R; Khademi M; Tarkowski A; Greitz D; Dahlström M; Lundberg I; Klareskog L; Olsson T
Ann Rheum Dis; 2001 Apr; 60(4):372-9. PubMed ID: 11247868
[TBL] [Abstract][Full Text] [Related]
51. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
52. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression.
Liu TF; Jones BM; Wong RW; Srivastava G
Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320
[TBL] [Abstract][Full Text] [Related]
53. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
Zhang X; Shu H; Zhang F; Tian X; Dong Y
Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
[TBL] [Abstract][Full Text] [Related]
54. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
55. Increased Macroautophagy in Interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus.
Luo XY; Yuan JL; Liu J; Luo CN; Yang MH; Wei Q; Yang M; Chen Y; Liu Y; Yuan GH
Chin Med J (Engl); 2018 Jul; 131(13):1527-1532. PubMed ID: 29941705
[TBL] [Abstract][Full Text] [Related]
56. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
57. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
58. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
59. Macrophage colony-stimulating factor could evaluate both disease activity and renal involvement in systemic lupus erythematosus.
Wang R; Zhao H; Liu Y; Li Y; Cai J
Ann Palliat Med; 2021 Feb; 10(2):2098-2107. PubMed ID: 33549023
[TBL] [Abstract][Full Text] [Related]
60. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
